Skip to content

Annexon ANNX Total Liabilities & Equity

Total Liabilities & Equity at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$40.87B+8.9%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.25B+258%
Omeros logo
OmerosOMER
$286.17M+21.7%
Vor Biopharma logo
Vor BiopharmaVOR
$506.75M+364%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$402.98M-30.5%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$763.27M+198%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$868.37M+233%
Enterprise value$718.59M+274%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's total liabilities & equity?
Annexon (ANNX) reported total liabilities & equity of $262.89M in Q1 2026.
How has Annexon's total liabilities & equity changed year-over-year?
Annexon's total liabilities & equity decreased by 13.2% year-over-year, from $303.03M to $262.89M.
What is the long-term trend for Annexon's total liabilities & equity?
Over 5 years (2020 to 2025), Annexon's total liabilities & equity has grown at a -4.9% compound annual growth rate (CAGR), from $355.95M to $277.57M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.